Advertisement Emerging Trends in Homogeneous Hydrogenation Catalysis - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

Emerging Trends in Homogeneous Hydrogenation Catalysis

By Johnson Matthey Fine Chemicals

Dr Antonio Zanotti-Gerosa and Dr Hans G Nedden of Johnson Matthey Catalysis and Chiral Technologies look at recent developments in catalysis for pharmaceuticals and fine chemicals.

The reduction of prochiral functional groups, C=C, C=O and C=N bonds using
homogeneous catalysis technology is becoming increasingly prevalent in the pharmaceuticals and fine chemicals industries.

The economics of such reactions must always be assessed in the context of various competitive and complementary technologies, namely biocatalysis and homogeneous and heterogeneous chemocatalysis. A thorough review can prove quite challenging without an extensive understanding of the complexities of catalytic performance.